Known targets — ChEMBL curated mechanism
ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.48 |
| ▸ | HTR2C known ✓ | P28335 | 1/20 | 0.48 |
| ▸ | KMO | O15229 | 2/20 | 0.53 |
| ▸ | ACLY | P53396 | 2/20 | 0.46 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.44 |
| ▸ | CDK4 | P11802 | 1/20 | 0.43 |
| ▸ | CCND1 | P24385 | 1/20 | 0.43 |
| ▸ | KRAS | P01116 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | PLG | P00747 | 1/20 | 0.39 |
| ▸ | PLAU | P00749 | 1/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.39 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL8959483 | 1.00 | KMO (0.53) | KMOHTR2AHTR2CACLYOXER1 | |
| Fumaric Acid SCHEMBL7673301 | 0.89 | KMO (0.68) | KMOACLYOXER1LMNAMAPT | |
| SCHEMBL8959527 | 0.87 | HTR2A (0.59) | KMOHTR2AHTR2CACLYOXER1 | |
| Hydrochloric Acid SCHEMBL27171474 | 0.85 | HTR2A (0.58) | KMOHTR2AHTR2CACLYOXER1 | |
| Hydrochloric Acid SCHEMBL29902400 | 0.85 | HTR2A (0.58) | KMOHTR2AHTR2CACLYOXER1 | |
| Fumaric Acid SCHEMBL8959686 | 0.84 | HTR2A (0.48) | HTR2AHTR2CCDK4CCND1LMNA | |
| Fumaric Acid SCHEMBL8959697 | 0.84 | HTR2A (0.48) | HTR2AHTR2CCDK4CCND1LMNA | |
| Fumaric Acid SCHEMBL8959632 | 0.83 | HDAC6 (0.54) | KMOHTR2AHTR2CKRASLMNA | |
| Fumaric Acid SCHEMBL8959620 | 0.83 | HDAC6 (0.54) | KMOHTR2AHTR2CKRASLMNA | |
| SCHEMBL1576323 | 0.81 | KMO (0.78) | KMOHTR2AHTR2CACLYOXER1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5494928-A | FOR CENTRAL NERVOUS SYSTEM DISORDERS, BLOCKING SEROTONIN RECEPTORS, ANTIDEPRESSANTS | HOFFMANN-LA ROCHE INC. (US) | 1996-02-27 | — | — | US | disclosed |